Talis Biomedical Corporation (TLIS)
OTCMKTS
· Delayed Price · Currency is USD
1.740
0.00 (0.00%)
Mar 28, 2025, 4:00 PM EST
Talis Biomedical Employees
Talis Biomedical had 99 employees as of December 31, 2023. The number of employees decreased by 3 or -2.94% compared to the previous year.
Employees
99
Change (1Y)
-3
Growth (1Y)
-2.94%
Revenue / Employee
$4,121
Profits / Employee
-$515,414
Market Cap
3.17M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 99 | -3 | -2.94% |
| Dec 31, 2022 | 102 | -160 | -61.07% |
| Dec 31, 2021 | 262 | 126 | 92.65% |
| Dec 31, 2020 | 136 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 2,931 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 413 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 9 |
| Silence Therapeutics | 116 |
| American Oncology Network | 1,525 |
Talis Biomedical News
- 6 months ago - Baker Bros. Advisors LP's Strategic Acquisition in Talis Biomedical Corp - GuruFocus
- 1 year ago - Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash - GlobeNewsWire
- 1 year ago - Talis Biomedical Corporation (TLIS) Q2 2023 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update - GlobeNewsWire
- 1 year ago - Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023 - GlobeNewsWire
- 1 year ago - Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO) - GlobeNewsWire
- 1 year ago - Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 1 year ago - Talis Biomedical Announces 1-for-15 Reverse Stock Split - GlobeNewsWire